Over the past 12 months, 4 insiders at Jasper Therapeutics, Inc. filed 4 open-market SEC Form 4 transactions on JSPR: 4 purchases worth $347K and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Sep 22, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 25 | Svetlana LucasDirector | BUY | 20.0K | $2.43 | $49K |
| Sep 22, 25 | Ron MartellPresident and CEO | BUY | 41.0K | $2.43 | $100K |
| Sep 22, 25 | Judith Anne ShizuruDirector | BUY | 41.0K | $2.43 | $100K |
| Sep 22, 25 | Thomas G WiggansDirector | BUY | 41.0K | $2.43 | $100K |
| Dec 12, 24 | Jeetinder Singh MahalChief Operating Officer | SELL | 900 | $22.11 | $20K |
| Sep 12, 24 | Jeetinder Singh MahalChief Operating Officer | SELL | 900 | $21.23 | $19K |
| Jun 12, 24 | Jeetinder Singh MahalChief Operating Officer | SELL | 900 | $24.16 | $22K |
| Mar 12, 24 | Jeetinder Singh MahalChief Operating Officer | SELL | 900 | $26.44 | $24K |
| Feb 8, 24 | Abingworth LlpTenPercentOwner | BUY | 190.0K | $12.95 | $2.5M |
| Feb 8, 24 | Balaji VenkataramanTenPercentOwner | BUY | 350.0K | $12.95 | $4.5M |
| Nov 28, 23 | Thomas G WiggansDirector | BUY | 10.0K | $0.65 | $7K |
| Nov 21, 23 | Thomas G WiggansDirector | BUY | 10.0K | $0.64 | $6K |
| Nov 20, 23 | Thomas G WiggansDirector | BUY | 10.0K | $0.63 | $6K |
| Nov 17, 23 | Thomas G WiggansDirector | BUY | 10.0K | $0.60 | $6K |
| Nov 16, 23 | Thomas G WiggansDirector | BUY | 10.0K | $0.60 | $6K |
| Oct 13, 23 | William LisDirector | SELL | 8.0K | $0.85 | $7K |
| Jun 13, 23 | Jeetinder Singh MahalSee Remarks | SELL | 9.0K | $1.66 | $15K |
| Apr 14, 23 | Anna Louise FrenchDirector | SELL | 7.0K | $1.48 | $10K |
| Apr 13, 23 | Kurt Von EmsterDirector | SELL | 9.1K | $1.49 | $14K |
| Apr 13, 23 | William LisDirector | SELL | 8.5K | $1.44 | $12K |
| Jan 27, 23 | Qiming U.s. Healthcare Gp Ii, LlcTenPercentOwner | BUY | 2.67M | $1.50 | $4.0M |
| Jan 27, 23 | Tc Group, LlcTenPercentOwner | BUY | 3.13M | $1.50 | $4.7M |
| Jan 25, 23 | Roche Finance LtdTenPercentOwner | SELL | 75.0K | $1.89 | $142K |
| Jun 27, 22 | William LisDirector | SELL | 24.7K | $2.08 | $51K |
| Jun 24, 22 | William LisDirector | SELL | 24.7K | $2.02 | $50K |
Over the past 12 months, insiders at Jasper Therapeutics, Inc. filed 4 open-market purchases worth $347K and 0 sales worth $0 on JSPR, which makes them net buyers over the period. The most recent Form 4 was filed on Sep 22, 25.
The largest recent open-market JSPR insider purchase in our data was $4.7M by Tc Group, Llc, TenPercentOwner, filed on Jan 27, 23.
4 different insiders at Jasper Therapeutics, Inc. filed open-market SEC Form 4 transactions on JSPR over the last 12 months.
InsiderTape plots every JSPR insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Jasper Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →